SGB-3403
/ Sanegene Bio
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 19, 2024
A Study to Evaluate SGB-3403 in Healthy Volunteers
(ANZCTR)
- P1 | N=37 | Terminated | Sponsor: Sanegene Bio Australia Pty Ltd | Initiation date: May 2023
Trial initiation date • Trial termination • Dyslipidemia • Metabolic Disorders • APOA1 • APOB
February 02, 2024
A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
(clinicaltrials.gov)
- P1 | N=64 | Not yet recruiting | Sponsor: Suzhou Sanegene Bio Inc.
New P1 trial • Dyslipidemia
1 to 2
Of
2
Go to page
1